Palisade Bio (PALI) Debt to Equity (2010 - 2025)
Palisade Bio (PALI) reported Debt to Equity of $0.07 for Q3 2025, up 190.44% on a QoQ basis from $0.03 in Q2 2025.
Palisade Bio (PALI) has 11 years of Debt to Equity data on file, last reported at $0.07 in Q3 2025.
- Quarterly Debt to Equity changed N/A year-over-year to $0.07 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $0.07 (changed N/A YoY) and the FY2023 annual result came in at $0.01, changed N/A from the prior year.
- Debt to Equity climbed to $0.07 in Q3 2025 per PALI's latest filing, from $0.03 in the prior quarter.
- Across five years, Debt to Equity topped out at $0.07 in Q3 2025 and bottomed at -$0.12 in Q2 2021.
- The 4-year median for Debt to Equity is $0.01 (2024), against an average of $0.01.
- The widest annual swing landed in 2021, when Debt to Equity surged 117.19%; it then decreased 8.91% in 2025.
- Tracing PALI's Debt to Equity over 4 years: stood at $0.01 in 2021, then advanced by 7.01% to $0.01 in 2023, then climbed by 18.48% to $0.01 in 2024, then jumped by 388.52% to $0.07 in 2025.
- Per Business Quant, the three latest PALI Debt to Equity figures stand at $0.07 (Q3 2025), $0.03 (Q2 2025), and $0.01 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.06 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 0.07 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Jun 30, 2021 | -0.12 |
| Dec 31, 2020 | -0.07 |
| Mar 31, 2017 | 0.26 |
| Dec 31, 2016 | 0.33 |
| Sep 30, 2016 | -1.28 |
| Jun 30, 2016 | 7.06 |
| Mar 31, 2016 | -41.40 |
| Dec 31, 2015 | 1.60 |
| Sep 30, 2015 | 1.02 |
| Jun 30, 2015 | 0.62 |
| Mar 31, 2015 | 0.46 |
| Dec 31, 2014 | 0.50 |
| Sep 30, 2014 | 0.12 |
| Jun 30, 2014 | 0.27 |
| Mar 31, 2014 | 0.26 |
| Dec 31, 2013 | 0.91 |
| Sep 30, 2013 | 0.84 |
| Jun 30, 2013 | 1.72 |
| Mar 31, 2013 | 1.33 |
| Dec 31, 2010 | 0.16 |